Bhaskar Gurram
Pediatric Gastroenterology · Dallas, TXNPI 1528244597
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,407 of the $4,370 with a category attached, or 78.0%. It is spread thinly across 21 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.
Across 148 payments — averaging $29.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$980
- AbbVie$635
- Janssen Scientific Affairs, LLC$541
- Takeda Pharmaceuticals U.S.A., Inc.$411
- Johnson & Johnson$348
- QOL Medical, LLC$300
- plus $1K from 15 others
Across 30 payments — averaging $2301.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$68K
- Eli Lilly$1K
Across 2 payments — averaging $5299.44 each. An ownership or investment interest held by the physician or an immediate family member.
- Scientia Vascular$11K
What the payments were for
- Travel & lodging$74517%
- Food & beverage$3,40778%
- Education$2185%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 11 | $980 |
| AbbVie | 34 | $635 |
| Janssen Scientific Affairs, LLC | 6 | $541 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $411 |
| Johnson & Johnson | 20 | $348 |
| QOL Medical, LLC | 11 | $300 |
| Mirum Pharmaceuticals, Inc. | 11 | $207 |
| Sanofi | 6 | $195 |
| Regeneron Healthcare Solutions, Inc. | 9 | $187 |
| 3-d Matrix, Inc. | 1 | $164 |
| Alcresta Therapeutics, Inc. | 5 | $119 |
| Pharming Healthcare, Inc. | 3 | $59 |
| Amgen | 2 | $47 |
| Nestle Healthcare Nutrition Inc. | 1 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Mauna Kea Technologies, Inc. | 1 | $24 |
| Intrabio Inc | 1 | $23 |
| AstraZeneca | 1 | $20 |
| Eton Pharmaceuticals, Inc. | 1 | $20 |
| Albireo Pharma, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,370 in reported general payments places this provider in the 80th percentile of 159 pediatric gastroenterology providers in Texas.
Other pediatric gastroenterology in Dallas
- Naveen MittalDallas$182K
- Amal AqulDallas$99K
- Charina RamirezDallas$60K
- Meghana SatheDallas$30K
- David TroendleDallas$14K
- Nandini ChannabasappaDallas$12K
- Rinarani SanghaviDallas$6K
- Bradley BarthDallas$6K
- Ricardo Medina-CentenoDallas$5K
- Megha MehtaDallas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.